Literature DB >> 3826511

Treatment of intestinal ischemia with oxygenated intraluminal perfluorocarbons.

K T Oldham, K S Guice, D Gore, W K Gourley, T E Lobe.   

Abstract

Liquid perfluorocarbons are biologically inert compounds capable of dissolving up to 40 percent oxygen by volume. This remarkable and reversible oxygen solubility has encouraged investigations into therapeutic application in situations where tissue oxygen delivery is impaired. One such setting is intestinal ischemia. Identically prepared devascularized segments of rat intestine were treated with either intraluminal oxygenated perfluorocarbon (perfluorotributylamine) or physiologic saline solution. After timed sacrifice, blinded quantitative histologic evaluation for ischemic injury was performed. The perfluorotributylamine treatment groups had histologic scores indicative of less severe injury between 1 and 4 hours. These scores achieved statistical significance (p less than 0.05). We conclude that intraluminal oxygenated perfluorocarbons have a significant protective effect in this model of intestinal ischemia. This quantitative analysis is unique and is an important aspect of the preclinical evaluation of the perfluorocarbon preparations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826511     DOI: 10.1016/0002-9610(87)90606-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Changes of gastric and intestinal blood flow, serum phospholipase A2 and interleukin-1beta in rats with acute necrotizing pancreatitis.

Authors:  Jian-Xin Zhang; Sheng-Chun Dang; Jian-Guo Qu; Xue-Qing Wang; Guo-Zuo Chen
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury.

Authors:  M G Caty; K S Guice; K T Oldham; D G Remick; S I Kunkel
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

3.  Intraluminal intestinal administration of oxygenated perfluorocarbon improves acid-base and cardiopulmonary parameters after acute mesenteric ischemia. An experimental study in rabbits.

Authors:  Dimitrios K Papadimitriou; Georgios A Pitoulias; Basilios T Papaziogas; Maria D Tachtsi; Eustratios D Kalaitzis
Journal:  Surg Today       Date:  2007-03-26       Impact factor: 2.549

4.  Mibefradil, a T-type Ca2+ channel blocker, protects against mesenteric ischemia-reperfusion-induced oxidative injury and histologic alterations in intestinal mucosa in rats.

Authors:  Hayrettin Ozturk; Hulya Ozturk; Hatun Duran; Ali Kemal Uzunlar
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

Review 5.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

6.  Transintestinal systemic oxygenation using perfluorocarbon.

Authors:  Naoyuki Miyaguchi; Itaru Nagahiro; Kazutoshi Kotani; Hidehiro Nakanishi; Hideaki Mori; Tomohiko Osaragi; Nobuyoshi Shimizu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Orchiectomy or testosterone receptor blockade reduces intestinal mucosal damage caused by ischemia-reperfusion insult.

Authors:  Bülent Akçora; Enes Altuğ; Tünay Kontaş; Sibel Hakverdi; Abdulkerim Temiz
Journal:  Pediatr Surg Int       Date:  2007-11-01       Impact factor: 1.827

8.  Transintestinal oxygenation with perfluorocarbon: investigation of perfusion rate.

Authors:  Kazutoshi Kotani; Itaru Nagahiro; Hidehiro Nakanishi; Hideaki Mori; Hiroshi Date; Nobuyoshi Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-10

9.  Antitumor effect of Streptococcus pyogenes by inducing hydrogen peroxide production.

Authors:  Y Higuchi
Journal:  Jpn J Cancer Res       Date:  1996-12

10.  Enhancement of the antitumor effect of glucose oxidase by combined administration of hydrogen peroxide decomposition inhibitors together with an oxygenated fluorocarbon.

Authors:  Y Higuchi; S Shoin; S Matsukawa
Journal:  Jpn J Cancer Res       Date:  1991-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.